Concepedia

Mingqiang Ren

MR

Statistics

Publications

27

Citations

1.2K

H-Index

23

Active since

2002

Affiliations

Augusta University(Current)

Augusta University Health

Georgia Regents Medical Center

National Cancer Center of Georgia

Roswell Park Comprehensive Cancer Center

Mingqiang Ren is an author at Augusta University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2002–2020

27

Publications

27

Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.

Silvia Maria Sirchia, Mingqiang Ren, Elena Sironi et al. · PubMed · 2002 · 153 citations · Full text

, , +17

Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1

Mingqiang Ren, Mei Hong, Gentao Liu et al. · Oncology Reports · 2013 · 76 citations · Full text

, , +13

Epigenetic Modulation of Retinoic Acid Receptor β2 by the Histone Deacetylase Inhibitor MS-275 in Human Renal Cell Carcinoma

Xiaofei Wang, David Z. Qian, Mingqiang Ren et al. · Clinical Cancer Research · 2005 · 75 citations

, , +17

Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility

Hui-min Zhou, Yuan-yuan Fang, Paul Weinberger et al. · BMC Cancer · 2016 · 73 citations · Full text

, , +17

Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1‐driven leukemia/lymphomas

John K. Cowell, Haiyan Qin, Tianxiang Hu et al. · International Journal of Cancer · 2017 · 71 citations · Full text

, , +17

1–5 of 27